Author
Listed:
- Sari Wulan Dwi Sutanegara
(University of Udayana/ Prof. Dr. I.G.N.G. Ngoerah General Hospital, Indonesia)
- Komang Andi Dwi Saputra
(University of Udayana/ Prof. Dr. I.G.N.G. Ngoerah General Hospital, Indonesia)
- I. Wayan Gede Artawan Eka Putra
(Udayana University, Indonesia)
- Ida Bagus Made Suryatika
(Udayana University, Indonesia)
- I. Made Nudi Arthana
(University of Udayana/ Prof. Dr. I.G.N.G. Ngoerah General Hospital, Indonesia)
Abstract
Background: Tinnitus is the perception of sound heard by a person without an external stimulus. Tinnitus can be divided into two, which tinnitus subjective and objective. About 10%–14.5% of the world’s population experience tinnitus. The management of tinnitus is still a challenge for researchers. Until now, there has been no effective management of tinnitus. The last therapy available is to make artificial sounds that imitate the tinnitus sound so that it can mask the actual tinnitus sound. In addition, Song therapy is expected to reduce the stress level of tinnitus patients. Methods: This research uses a double-blind randomized clinical trial with stratified and matching risk factors from the sample then the sample is randomized to get 104 samples consisting of 52 control groups and 52 experimental groups. Both groups will be assessed objectively with the Tinnitus Handicap Inventory (THI), and Tinnitus Primary Function Questionnaire (TPFQ), and subjectively with the Visual Analog Scale (VAST) before and after using the application. Assessment is done using the google form. The control group will be given an application containing a sound generator and the experimental group will be given an application containing de tinnitus Song. Both groups used the app for 2 hours daily for 3 months. Song de tinnitus was obtained from previous studies. Results: The difference in risk factors in the two groups was 0.01 and the data obtained to be tested is normally distributed with the Kolmogorov Smirnov test (Sig > 0.1). We used a significance level of 95% and a research power of 0.1 with the result that there was a difference between the control group and the experimental group, better on the experimental group test with Chi-Square THI (p ∼ 0.005), TPFQ (p ∼ 0.004) and VAST (p ∼ 0.002). THI (Relative risk reduction (RRR) = 59% Absolute risk reduction (ARR) = 25%, number needed to treat (NNT) = 4, TPFQ (RRR = 53.84%, ARR = 26.92%, NNT = 3.71) and VAST (RRR = 72.22%, ARR = 25%, NNT = 4). Conclusion: We got better results using the app with de tinnitus Song (Music de Tinnitus) than using standard therapy.
Suggested Citation
Sari Wulan Dwi Sutanegara & Komang Andi Dwi Saputra & I. Wayan Gede Artawan Eka Putra & Ida Bagus Made Suryatika & I. Made Nudi Arthana, 2023.
"Randomized Clinical Trial: Effectiveness of Tinnitus Treatment Using Music de Tinnitus Therapy Compared with Standard Therapy,"
European Journal of Clinical Medicine, European Open Science, vol. 4(6), pages 1-6, November.
Handle:
RePEc:epw:clinic:v:4:y:2023:i:6:id:12321
DOI: 10.24018/clinicmed.2023.4.6.321
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:clinic:v:4:y:2023:i:6:id:12321. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support Team (email available below). General contact details of provider: https://eu-opensci.org/index.php/clinicmed .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.